Decreased native renal T(1) up to one week after gadobutrol administration in healthy volunteers

BACKGROUND: Gadolinium‐based contrast agents (GBCAs) are widely used in MRI, despite safety concerns regarding deposition in brain and other organs. In animal studies gadolinium was detected for weeks after administration in the kidneys, but this has not yet been demonstrated in humans. PURPOSE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Anneloes, Harteveld, Anita A., Pieters, Tobias T., Blankestijn, Peter J., Bos, Clemens, Froeling, Martijn, Joles, Jaap A., Verhaar, Marianne C., Leiner, Tim, Hoogduin, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496302/
https://www.ncbi.nlm.nih.gov/pubmed/31799793
http://dx.doi.org/10.1002/jmri.27014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496302/
https://www.ncbi.nlm.nih.gov/pubmed/31799793
http://dx.doi.org/10.1002/jmri.27014

Ejemplares similares